Source: NantHealth Vimeo Channel

NantHealth posted a video "GPS Cancer Intro by Dr. Patrick" on VIMEO

GPS Cancer is a unique molecular test offered by NantHealth that integrates quantitative targeted proteomics detected by mass spectrometry with whole genome (DNA) and whole transcriptome (RNA) sequencing, of both normal and cancer tissue.An overview of GPS Cancer by Dr. Patrick Soon-Shiong, CEO of NantHealth. Personalized Molecular Decision Support for Cancer Therapy Before Treatment BeginsCast: NANTHEALTH LLCTags: precision medicine, gps, immunotherapy, sequencing, test, cancer, DNA, RNA and genomics

See Video »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Patrick Soon-Shiong's photo - Chairman & CEO of NantHealth

Chairman & CEO

Patrick Soon-Shiong

CEO Approval Rating

89/100

NantHealth is a cloud-based medical Information Technology platform that enables medical professionals to share and deliver healthcare information. Read more